Literature DB >> 27694168

Evaluation of Prostate Cancer with 11C-Acetate PET/CT.

Claudio Spick1, Ken Herrmann1, Johannes Czernin2.   

Abstract

In this article, we will first describe the metabolic fate of 11C-acetate; then discuss its biodistribution in health and disease; and subsequently focus on its key clinical applications, the detection and localization of prostate cancer tissue in patients with primary or recurrent disease. Finally, we will discuss the potential role of 11C-acetate in the context of other prostate cancer imaging probes and non-radionuclide-based imaging approaches.
© 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27694168     DOI: 10.2967/jnumed.115.169599

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  14 in total

Review 1.  Acetyl-CoA Synthetase 2 as a Therapeutic Target in Tumor Metabolism.

Authors:  Mengfang Liu; Na Liu; Jinlei Wang; Shengqiao Fu; Xu Wang; Deyu Chen
Journal:  Cancers (Basel)       Date:  2022-06-12       Impact factor: 6.575

Review 2.  Cancer cell metabolic plasticity in migration and metastasis.

Authors:  Jenna A Mosier; Samantha C Schwager; David A Boyajian; Cynthia A Reinhart-King
Journal:  Clin Exp Metastasis       Date:  2021-06-02       Impact factor: 5.150

Review 3.  Tumour metabolism and its unique properties in prostate adenocarcinoma.

Authors:  David A Bader; Sean E McGuire
Journal:  Nat Rev Urol       Date:  2020-02-28       Impact factor: 14.432

4.  Propionic Acid-Based PET Imaging of Prostate Cancer.

Authors:  Zhanwen Zhang; Shaoyu Liu; Hui Ma; Xianhong Xiang; Dahong Nie; Ping Hu; Ganghua Tang
Journal:  Mol Imaging Biol       Date:  2021-04-19       Impact factor: 3.488

5.  Targeting ACSS2 with a Transition-State Mimetic Inhibits Triple-Negative Breast Cancer Growth.

Authors:  Katelyn D Miller; Katherine Pniewski; Caroline E Perry; Sara B Papp; Joshua D Shaffer; Jesse N Velasco-Silva; Jessica C Casciano; Tomas M Aramburu; Yellamelli V V Srikanth; Joel Cassel; Emmanuel Skordalakes; Andrew V Kossenkov; Joseph M Salvino; Zachary T Schug
Journal:  Cancer Res       Date:  2021-01-07       Impact factor: 13.312

6.  Method to Development of PET Radiopharmaceutical for Cancer Imaging.

Authors:  Naresh Damuka; Kiran Kumar Solingapuram Sai
Journal:  Methods Mol Biol       Date:  2022

Review 7.  Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment.

Authors:  Kaitlin Graham; Evan Unger
Journal:  Int J Nanomedicine       Date:  2018-10-04

8.  When fat goes down, prostate cancer is on the ropes.

Authors:  Giorgia Zadra; Massimo Loda
Journal:  Mol Cell Oncol       Date:  2019-04-16

Review 9.  Imaging Cancer Metabolism: Underlying Biology and Emerging Strategies.

Authors:  Austin R Pantel; Daniel Ackerman; Seung-Cheol Lee; David A Mankoff; Terence P Gade
Journal:  J Nucl Med       Date:  2018-07-24       Impact factor: 10.057

10.  Bispecific GRPR-Antagonistic Anti-PSMA/GRPR Heterodimer for PET and SPECT Diagnostic Imaging of Prostate Cancer.

Authors:  Bogdan Mitran; Zohreh Varasteh; Ayman Abouzayed; Sara S Rinne; Emmi Puuvuori; Maria De Rosa; Mats Larhed; Vladimir Tolmachev; Anna Orlova; Ulrika Rosenström
Journal:  Cancers (Basel)       Date:  2019-09-14       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.